Related Experiment Video
Updated: May 21, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Rewiring drug-activated p53-regulatory network from suppressing to promoting tumorigenesis
Wei Song1, Jiguang Wang, Ying Yang
1Key Laboratory of Systems Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Abstract:
Many of oncogenes and tumor suppressor genes have been found to exert variable and even opposing roles in different kinds of tumors or at different stages of cancer development. Here we showed that tumorigenic potential of mouse embryonic carcinoma P19 cells cultured in adherent plates (attached-P19-cells) was suppressed by a chemotherapeutic agent, 5-aza-2'-deoxycytidine (ZdCyd), whereas the higher pro-tumorigenicity of P19 cells growing in suspension (detached-P19-cells) was generated by the ZdCyd treatment. Surprisingly, p53 activity was highly up-regulated by ZdCyd in both growing conditions. By our developed computational approaches, we revealed that there was a significant enrichment of apoptotic pathways in the ZdCyd-induced p53-dominant gene-regulatory network in attached P19 cells, whereas the pro-survival genes were significantly enriched in the ZdCyd-induced p53 network in detached P19 cells. The protein-protein interaction network of the ZdCyd-treated detached P19 cells was significantly different from that of ZdCyd-treated attached P19 cells. On the other hand, inhibition of p53 expression by siRNA suppressed the ZdCyd-induced tumorigenesis of detached P19 cells, suggesting that the ZdCyd-activated p53 plays oncogenic function in detached P19 cells. Taken together, these results indicate a context-dependent role for the ZdCyd-activated p53-dominant network in tumorigenesis.
Insights
The chemotherapeutic agent 5-aza-2'-deoxycytidine (ZdCyd) differentially affects mouse P19 cell tumorigenicity. ZdCyd suppresses attached cells but promotes suspended cells, with context-dependent p53 network roles in cancer development.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Epigenetics
Background:
- Oncogenes and tumor suppressor genes can have opposing roles depending on tumor type and stage.
- The chemotherapeutic agent 5-aza-2 '-deoxycytidine (ZdCyd) is a DNA methyltransferase inhibitor.
Purpose of the Study:
- To investigate the context-dependent effects of ZdCyd on P19 cell tumorigenicity.
- To elucidate the role of p53 in ZdCyd-mediated alterations of P19 cell behavior.
Main Methods:
- Treatment of P19 cells (attached and detached) with ZdCyd.
- Analysis of p53 activity and gene expression profiles.
- Computational approaches to analyze gene-regulatory and protein-protein interaction networks.
- siRNA-mediated inhibition of p53.
Main Results:
- ZdCyd suppressed tumorigenicity in attached P19 cells but enhanced it in detached P19 cells.
- p53 activity was upregulated by ZdCyd in both conditions.
- Apoptotic pathways were enriched in attached cells, while pro-survival pathways were enriched in detached cells.
- ZdCyd-activated p53 exhibited oncogenic function in detached P19 cells.
Conclusions:
- The p53-dominant network activated by ZdCyd plays context-dependent roles in tumorigenesis.
- These findings highlight the complex, condition-specific functions of p53 in cancer.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle